- Report
- March 2024
- 197 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- November 2023
- 145 Pages
Global
From €2416EUR$2,499USD£2,075GBP
- Report
- June 2023
- 140 Pages
Global
From €2416EUR$2,499USD£2,075GBP
- Report
- February 2024
- 400 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- November 2023
- 250 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- November 2023
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- July 2023
- 80 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- March 2024
- 146 Pages
Global
From €3770EUR$3,899USD£3,238GBP
- Report
- February 2024
- 200 Pages
Global
From €4689EUR$4,850USD£4,028GBP
- Report
- January 2024
- 220 Pages
Global
From €2407EUR$2,490USD£2,068GBP
- Report
- November 2023
- 189 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- November 2023
- 182 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- November 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- October 2023
- 180 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- February 2024
- 130 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- December 2023
- 88 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- November 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- October 2023
- 181 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,446GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,446GBP
Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more